Innovative Medicine : : Basic Research and Development.
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | Tokyo : : Springer Japan,, 2015. ©2015. |
Year of Publication: | 2015 |
Edition: | 1st ed. |
Language: | English |
Online Access: | |
Physical Description: | 1 online resource (330 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
LEADER | 12164nam a22004693i 4500 | ||
---|---|---|---|
001 | 5006422590 | ||
003 | MiAaPQ | ||
005 | 20240229073837.0 | ||
006 | m o d | | ||
007 | cr cnu|||||||| | ||
008 | 240229s2015 xx o ||||0 eng d | ||
020 | |a 9784431556510 |q (electronic bk.) | ||
020 | |z 9784431556503 | ||
035 | |a (MiAaPQ)5006422590 | ||
035 | |a (Au-PeEL)EBL6422590 | ||
035 | |a (OCoLC)1156906627 | ||
040 | |a MiAaPQ |b eng |e rda |e pn |c MiAaPQ |d MiAaPQ | ||
050 | 4 | |a R850.A1-854 | |
082 | 0 | |a 616 | |
100 | 1 | |a Nakao, Kazuwa. | |
245 | 1 | 0 | |a Innovative Medicine : |b Basic Research and Development. |
250 | |a 1st ed. | ||
264 | 1 | |a Tokyo : |b Springer Japan, |c 2015. | |
264 | 4 | |c ©2015. | |
300 | |a 1 online resource (330 pages) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
505 | 0 | |a Intro -- Preface -- Contents -- Part I: Basic Research for Innovative Medicine -- Diverting Glycolysis to Combat Oxidative Stress -- Chemical Definition and Sources of ROS -- Physiology of ROS -- Biochemical Mechanisms that Preserve Redox Homeostasis -- Metabolic Adaptations to ROS -- The Pentose Phosphate Pathway and NADPH Production -- Phosphofructokinase-1 Inhibition -- Glyceraldehyde 3-Phosphate Dehydrogenase Inhibition -- Pyruvate Kinase M2 Inhibition -- De Novo Serine Synthesis -- Conclusion -- References -- Metabolic Regulation by Nuclear Receptors -- Introduction -- NR Endogenous Ligands Are Dietary Sensors -- Gut and Gut Microbiota -- De Novo Lipogenesis -- Integrative Physiology-Nuclear Receptor-Mediated Crosstalk -- Fibroblast Growth Factors -- Lipids -- Concluding Remarks -- References -- Fighting Fire with Fire in Cancer -- Introduction -- Boosting the Immune System -- Targeting CTLA-4 -- IL-7 Treatment -- Targeting Cancer Cell Metabolism -- Targeting Carnitine Palmitoyltransferase-1C -- Targeting Mutated Isocitrate Dehydrogenases -- Targeting Reactive Oxygen Species -- Exploiting Cancer Cell Aneuploidy -- Conclusion -- References -- Linear Polyubiquitination: A Crucial Regulator of NF-κB Activation -- The Ubiquitin Conjugation System -- The Canonical NF-κB Activation Pathways -- The Linear Ubiquitin Chains and Their Roles in NF-κB Activation -- Mechanism Underlying Linear Ubiquitin Chain-Mediated NF-κB Activation -- Perspectives -- References -- VCP, a Major ATPase in the Cells, as a Novel Drug Target for Currently Incurable Disorders -- Background -- VCP in Neurodegenerative Disorders -- Development of Novel Inhibitors (KUSs) of VCP ATPase Activity That Do Not Block VCP Cellular Functions -- KUSs Protected Cells Under ER Stress-Inducing Conditions -- KUSs or Exogenous ATP Prevented ER Stress in Cultured Cells. | |
505 | 8 | |a KUSs Mitigated Pathologies of rd10, a Mouse Model of Retinitis Pigmentosa -- Discussion -- References -- Roles of E-cadherin in Hepatocarcinogenesis -- Introduction -- Results -- Physiological Function of E-cadherin in the Liver -- Progenitor Cell Proliferation in CDH1ΔL Mice -- Loss of E-cadherin Accelerates Oncogene-Addicted Liver Carcinogenesis -- Loss of E-cadherin Promotes Chemical-Induced HCC -- Relationship Between E-cadherin Loss and Mesenchymal and Stem Cell Markers in Human HCC -- Discussion -- References -- The Hippo Signaling Pathway: A Candidate New Drug Target for Malignant Tumors -- Introduction -- Loss of Hippo Signaling in the Liver -- Loss of Hippo Signaling in the Pancreas -- Loss of Hippo Signaling in the Intestine -- Loss of Hippo Signaling in the Lung -- Loss of Hippo Signaling in the Skin -- Loss of Hippo Signaling in T Lymphocytes -- Loss of Hippo Signaling in Salivary Glands -- Loss of Hippo Signaling in Neurons -- Loss of Hippo Signaling in Bone -- Concluding Remarks -- References -- Inhibitory Immunoreceptors on Mast Cells in Allergy and Inflammation -- Introduction -- Allergin-1 -- Identification of Allergin-1 -- Expression of Allergin-1 -- Function of Allergin-1 -- In Vitro Analyses of Allergin-1 -- In Vivo Analyses of Allergin-1 -- CD300a -- Identification and Expression of CD300a -- Identification of a Ligand for CD300a -- Function of CD300a -- In Vitro Analyses of CD300a -- In Vivo Analyses of CD300a -- Blockade of CD300a-PS Interaction Prolonged Survival of Mice After CLP -- Conclusion -- References -- Doxycycline-Inducible Autoimmune Blistering Skin Disease Model -- Bullous Pemphigoid (BP), The Most Common Autoimmune Blistering Disease -- Clinical Features of BP -- Pathogenesis of BP -- COL17 as a Main AutoAg for BP -- BP Models Produced by "Humanization of Autoantigen" -- Generation of COL17-Humanized Mice. | |
505 | 8 | |a Neonatal BP Model Induced by Maternally Transferred Abs to Human COL17 -- Active BP Model -- Doxycycline-Inducible BP Model -- Perspectives -- References -- T Cell Senescence and Autoimmunity -- Introduction: Immune Aging and Senescence- Associated T Cells -- SA-T Cells Represent an Endogenously Arising Follicular T Cell Population with Age -- SA-T Cells Increase Robustly in Bone Fide Lupus-Prone Mice -- SA-T Cells Show Typical Signs and Features of Cellular Senescence -- SA-T Cells Are Activated in Response to Autologous GC B Cells to Produce OPN that Protects Against B Cell Apoptosis in GCs -- Involvement of SA-T Cells in the Expansion of GCs and Autoimmunity in Lupus -- Conclusion and Perspectives -- References -- Part II: Translational Research for Innovative Medicine -- IL-6: A New Era for the Treatment of Autoimmune Inflammatory Diseases -- Introduction -- Pleiotropic Function of IL-6 -- Effect of IL-6 in Immune Response -- Effect of IL-6 in Acute-Phase Response -- Other Effects of IL-6 -- IL-6 Signaling Systems -- Regulatory Mechanisms of IL-6 Synthesis -- Transcriptional and Post-transcriptional Regulation of IL-6 -- Pathological Role of IL-6 in Autoimmune Inflammatory Diseases -- IL-6-Targeting Strategies: A New Era for the Treatment of Autoimmune Inflammatory Diseases -- Efficacy of Tocilizumab in Rheumatoid Arthritis -- Efficacy of Tocilizumab in Systemic Juvenile Idiopathic Arthritis -- Efficacy of Tocilizumab in Castleman's Disease -- Efficacy of Tocilizumab in Other Autoimmune Inflammatory Diseases -- Mechanisms Through Which Tocilizumab Is Efficacious in Various Autoimmune Inflammatory Diseases -- Concluding Remarks -- References -- Pathogenesis of Non-alcoholic Steatohepatitis and Its Potential Therapeutic Strategies -- Introduction -- Interaction Between Adipocytes and Macrophages in Obese Adipose Tissue. | |
505 | 8 | |a Development of a Novel Rodent Model of NASH -- Identification of Hepatic Crown-Like Structure (hCLS) -- Macrophage-Induced C-Type Lectin (Mincle) -- Role of Mincle in Adipose Tissue Remodeling and Ectopic Fat Accumulation -- Summary -- References -- Multifaceted Translational Approach to Major Mental Illness -- Introduction -- Major Mental Illness Caused by a Combination of Multiple Genetic Risk Factors and Environmental Stressors in the Pathological Trajectory -- Research Infrastructure That Allows a Multifaceted Translational Approach to Major Mental Illness -- Two Representative Studies that Use the Research Infrastructure -- References -- Translational Research of Leptin in Lipodystrophy and Its Related Diseases -- Introduction -- Transgenic Mice Overexpressing Leptin -- Crossbreeding Experiment of LepTg Mice with A-ZIPTg Mice -- Leptin Replacement Therapy in Japanese Patients with Lipodystrophy -- Significance of Hepatic AMPK in the Metabolic Action of Leptin -- fMRI Analysis of Food-Related Brain Activity in Patients with Lipodystrophy -- Conclusions -- References -- Translational Research of the Activation of the C-Type Natriuretic Peptide (CNP)-Guanylyl Cyclase-B Pathway for Skeletal Dysplasia -- Introduction -- Skeletal Phenotypes of the CNP/GC-B System in Genetically Engineered Mice -- Importance of CNP/GC-B Signaling in Endochondral Bone Growth in Humans: Lessons from Rare Congenital Skeletal Disorders -- Translational Research into Activation of CNP/GC-B Signaling for Skeletal Dysplasias -- Conclusions and Future Prospects -- References -- Clarity and Challenges in Tissue Fibrosis -- Introduction -- Liver Fibrosis -- Mechanisms -- Role of Autophagy -- Genetic Models of Liver Fibrosis -- Reversibility of Hepatic Fibrosis -- Genomics of Fibrosis -- Framework for Antifibrotic Therapies -- Summary -- References. | |
505 | 8 | |a TRP Channels: Their Function and Potentiality as Drug Targets -- Introduction -- Modulation of Trpa1 Channel Activity -- Oxidation Sensitivity of the Trpa1 Channel -- Modulation of Trpa1 by Other Activators and Inhibitors -- Subtype-Selective S-Nitrosylation by a Novel Nitrosamine -- TRPC Channels as Therapeutic Targets for Heart Failure -- Structure and Function of TRPC Channels -- Role of TRPC Channels in Pathological Cardiac Remodeling -- Negative Feedback Mechanism in TRPC Channels -- Suppression of Pathological Cardiac Hypertrophy by TRPC3/6 Inhibition -- Conclusion -- References -- Autophagic Cell Death and Cancer Chemotherapeutics -- Apoptosis and Other Types of Cell Death -- Autophagy -- Alternative Macroautophagy -- Autophagic Cell Death -- Cancer and Autophagic Cell Death -- Autophagic Cell Death and Cancer Chemotherapeutics -- References -- Adrenomedullin as a Potential Therapeutic Agent for Refractory Ulcerative Colitis -- Introduction -- Basic Characteristics of AM -- Pathophysiological Roles of AM in Inflammation -- Preclinical Pharmacological Effect of AM in Experimental Model of Colitis -- Exploratory Clinical Study of AM as a Therapeutic Agent for Refractory Ulcerative Colitis -- Conclusion -- References -- RNA Activation -- Introduction -- Molecular Mechanism -- saRNA-Associated Proteins -- Argonaute Proteins -- Heterogeneous Nuclear RNA-Binding Proteins -- Histone Modification Enzymes -- Target Site Selection of saRNA -- Application of saRNA -- Stem Cell Differentiation -- Clinical Therapy (Regenerative Medicine) -- Concluding Remarks -- References -- Part III: New Technology for Innovative Medicine -- Proceedings of the Uehara Memorial Foundation. Innovative Medicine: Basic Research and Development. Cardiac Reprogramming for Heart Repair -- Introduction -- Cell Fate Conversion by Transcription Factors. | |
505 | 8 | |a Direct Reprogramming of Mouse Fibroblasts into Cardiomyocytes in Vitro. | |
588 | |a Description based on publisher supplied metadata and other sources. | ||
590 | |a Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. | ||
655 | 4 | |a Electronic books. | |
700 | 1 | |a Minato, Nagahiro. | |
700 | 1 | |a Uemoto, Shinji. | |
776 | 0 | 8 | |i Print version: |a Nakao, Kazuwa |t Innovative Medicine |d Tokyo : Springer Japan,c2015 |z 9784431556503 |
797 | 2 | |a ProQuest (Firm) | |
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/oeawat/detail.action?docID=6422590 |z Click to View |